HIV and hepatitis B coinfection follow-up study in Europe
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study follows people who have both HIV and hepatitis B over time to better understand how the infection responds after starting treatment. Your information (and sometimes stored blood samples) helps researchers track changes from the start of therapy to about 2 years later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are part of a participating (contributing) study cohort
- You have a hepatitis B test called HBsAg that is positive at least twice, with the tests more than 6 months apart
- You have at least one set of information at the start of treatment and additional information about 2 years later after starting TDF or TAF
- The 2-year information can be from regular study visits or from stored samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study follows people with hepatitis B (a liver infection) in Zambia to understand how their bodies respond to treatment and what happens to the virus over time. It includes people with hepatitis B alone, those also living with HIV, and those whose hepatitis B has cleared.
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
This study follows people with hepatitis B (HBV) blood tests that have improved over the last year. It aims to learn what happens after the hepatitis B surface antigen (HBsAg) goes down, and may help doctors better predict outcomes.
This study tests two ways to simplify your HIV and hepatitis B treatment while keeping the viruses controlled. By switching to a simpler combination, the goal is to maintain low viral levels and reduce the number of medicines you take.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study is looking for people in south-east Austria who have hepatitis B (HBV) or hepatitis C (HCV) that hasn't been fully treated or documented. It aims to find how many people also have hepatitis D (HDV) and are not yet aware of it.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.